In addition, PNVs and EA mitigated hepatic fibrosis, as indicated by Sirius red staining and the reduced levels of TGF, α‐SMA, and MMP2 in WD‐mediated MASLD. Here, ACTA1 is linked to metabolic dysfunction-associated steatotic liver disease.